What is Carbohydrase And Protease, Mixture, From Bacillus Subtilis?
Carbohydrase and Protease Mixture from Bacillus subtilis is an enzyme preparation containing two types of enzymes derived from the bacterium Bacillus subtilis. Carbohydrases are enzymes that break down complex carbohydrates into simpler sugars, while proteases cleave peptide bonds in proteins, breaking them into smaller peptides and amino acids. This mixture combines both enzymatic activities in a single preparation, allowing simultaneous hydrolysis of carbohydrates and proteins during food processing.
Bacillus subtilis is a naturally occurring, non-pathogenic soil bacterium that has been used safely in industrial enzyme production for decades. The enzyme mixture is manufactured through fermentation processes and is then purified and concentrated for use as a food processing aid.
Common Uses
This enzyme mixture is used in various food manufacturing applications:
- **Baking**: Enhances dough conditioning and improves bread texture and volume by breaking down carbohydrates and improving gluten structure
- **Brewing and Distilling**: Aids in the breakdown of grains during fermentation
- **Juice and Beverage Production**: Clarifies juices by reducing turbidity through enzymatic breakdown of carbohydrates and proteins
- **Dairy Products**: Improves texture and processing characteristics in cheese and yogurt production
- **Meat Processing**: Tenderizes meat products by breaking down connective tissue proteins
- **Animal Feed**: Enhances nutritional availability in feed formulations
As a processing enzyme, residual enzyme activity is typically inactivated or removed during final processing, heating, or shelf storage, making it primarily a processing aid rather than a final food component.
Safety Assessment
The safety profile of enzymes derived from Bacillus subtilis is generally well-established in food science. Key safety considerations include:
**Source Organism**: Bacillus subtilis is non-pathogenic and has been used in industrial food enzyme production since the 1970s. It lacks known toxins and does not produce harmful metabolites under fermentation conditions used for enzyme production.
**FDA Status**: This specific enzyme mixture is not currently on the FDA's Generally Recognized as Safe (GRAS) list, meaning it has not undergone the formal GRAS notification process. However, the absence of GRAS status does not indicate safety concerns; rather, it reflects that manufacturers have not submitted a GRAS notice to FDA.
**Adverse Events**: No adverse events have been reported to the FDA related to this enzyme mixture, indicating a lack of identified safety concerns in the food supply.
**Recalls**: No FDA recalls have been associated with this additive, further supporting an established safety history.
**Protein Allergenicity**: Like all enzyme preparations from fermentation, theoretical concerns exist regarding potential allergenic proteins. However, enzyme preparations are used at very low levels in food, and modern manufacturing processes include purification steps that minimize microbial protein content.
Regulatory Status
Regulatory approval for enzyme preparations varies globally:
- **United States**: While not listed as GRAS through formal notification, similar Bacillus subtilis enzyme preparations are permitted under FDA regulations (21 CFR 184.1005 for Bacillus subtilis protease). Manufacturers may use this enzyme under the presumption of GRAS status based on substantial equivalence to approved preparations or may conduct their own GRAS determination.
- **European Union**: Enzyme preparations are regulated under EC Regulation 1331/2008. Similar carbohydrase and protease combinations from Bacillus species have been evaluated and authorized for food use in the EU.
- **Japan and Other Markets**: Similar preparations are approved in most major food markets.
Enzymes are typically classified as processing aids rather than food additives because they are inactivated or removed during food processing, leaving no functional residues in finished foods.
Key Studies
Scientific literature on Bacillus subtilis enzyme preparations demonstrates safety:
- Historical use data from industrial enzyme manufacturers show no adverse health effects from occupational exposure or food applications spanning multiple decades.
- Safety assessments conducted by enzyme manufacturers and regulatory bodies have consistently supported the GRAS status of similar Bacillus subtilis protease preparations.
- Fermentation studies confirm that Bacillus subtilis under standard production conditions does not produce mycotoxins, antibiotics, or other secondary metabolites that would pose safety risks.
- Enzyme specifications and manufacturing controls ensure consistency and purity of final enzyme preparations used in food.
The long history of use in industrial food processing, combined with the established safety of the source organism and the low levels of enzyme use, support the overall safety of this enzyme mixture in food applications.